2WBY
Crystal structure of human insulin-degrading enzyme in complex with insulin
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 14-BM-C |
Synchrotron site | APS |
Beamline | 14-BM-C |
Temperature [K] | 287 |
Detector technology | CCD |
Collection date | 2007-06-11 |
Spacegroup name | P 65 |
Unit cell lengths | 262.319, 262.319, 90.609 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 32.080 - 2.600 |
R-factor | 0.167 |
Rwork | 0.164 |
R-free | 0.21800 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2g47 |
RMSD bond length | 0.024 |
RMSD bond angle | 2.101 |
Data reduction software | HKL-2000 |
Data scaling software | SCALEPACK |
Phasing software | PHASER |
Refinement software | REFMAC (5.2.0019) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 2.690 |
High resolution limit [Å] | 2.600 | 2.600 |
Rmerge | 0.130 | 0.520 |
Number of reflections | 109017 | |
<I/σ(I)> | 21 | 4.8 |
Completeness [%] | 99.9 | 100 |
Redundancy | 7 | 6.5 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | 7 | 10-13% PEG MME 5000, 100 MM HEPES PH 7.0, 4-14% TACSIMATE, 10% DIOXANE |